We focus on the basic "S-E-C" of biopharmaceuticals: the competitive advantages involving Safety, Efficacy, and/or
Convenience. We help our clients take an objective, data-driven approach to science, development, and marketing. That
way, we work to Manage Risk.
Convenience. We help our clients take an objective, data-driven approach to science, development, and marketing. That
way, we work to Manage Risk.
- Due Diligence for in-licensing and out-licensing candidates & proposals to acquire capital funding
- Comprehensive support for Scientific Advisory Board meetings
- Expert medical writing, including publication & messaging strategies, NDA document preparation/review
Recent Projects
| De Young & Hayden, LLC (DYH) |
"We recently worked with De Young & Hayden to create the CTD preclinical summaries and overview for an important new
NDA fling. I am very happy to report that the regulatory authorities had very few questions, saving the company much time
and money. We are very pleased with the results."
NDA fling. I am very happy to report that the regulatory authorities had very few questions, saving the company much time
and money. We are very pleased with the results."
 | |  | |  | |  | |  | |  |
- Trouble-shooting of company plans, processes, and projects
- In-depth KOL interviews and marketing research
- New product assessment and development
- Creating, testing & validating Target Product Profiles
- Design and assessment of clinical development programs
- Preparing Development teams for Regulatory meetings & scientific training support for Sales
"Appreciate your work . . . you were able to dig through the data and find things we had not previously identified."
Lead Pharmacologist, Swiss Multinational Pharmaceutical Company
VP of Sales, Medical Device Manufacturer